Select the pathological grade from the biopsy report to visualize the Marsh classification clinical profile.
Guidelines & Evidence
Clinical Details
Section 1
When to Use
When to Use
Evaluation of duodenal biopsies in patients with suspected Celiac Disease (CD)
Standardizing the degree of mucosal damage for pathology reports
To correlate histological findings with serological markers (tTG-IgA) and clinical symptoms
Monitoring mucosal healing in patients on a long-term gluten-free diet (GFD)
Biopsy Requirement
Accurate grading requires multiple biopsies (at least 4 from the second part of the duodenum and ideally 2 from the duodenal bulb at the 9 and 12 o'clock positions).
Section 2
Formula & Logic
The Modified Marsh Scale
Type 0
Normal mucosa (Pre-infiltrative)
Type 1
Infiltrative: Increased IELs (> 25 per 100 enterocytes); normal villi.
Type 2
Hyperplastic: Increased IELs + Crypt hyperplasia; normal villi.
The Oberhuber modification (1999) lowered the threshold for "increased IELs" to > 25 per 100 enterocytes. Type 3 is often considered the definitive "diagnostic" stage for Celiac Disease.
Section 3
Pearls/Pitfalls
Marsh 1 — The Diagnostic Dilemma
Isolated increase in IELs (Marsh 1) is not specific for Celiac Disease. It can be seen in H. pylori infection, NSAID use, SIBO, or common variable immunodeficiency (CVID). Always correlate with HLA-DQ2/8 and tTG serology before diagnosing CD at this stage.
Pathologist Variability
There is significant inter-observer variability in distinguishing 3a vs. 3b. For clinical decision-making, the broader category of "Type 3" (Villous Atrophy) is the most critical actionable finding.
Clinical Pearls
Marsh 3c is strongly associated with high titers of tTG-IgA (> 10x ULN)
Refractory Celiac Disease (RCD) is suggested by persistent Marsh 3 findings despite > 12 months of strict GFD
In children, the 2020 ESPGHAN guidelines allow for a non-biopsy diagnosis if tTG is > 10x ULN and EMA is positive
Professor Michael Marsh, an English pathologist, moved the field away from the binary "sprue vs. normal" toward a biological spectrum. He proved that Celiac disease was an immunological "process" that started with lymphocyte infiltration long before the total destruction (atrophy) of the villi.